Samuel Simone, MD
Vascular Surgery · Pittsburgh, PANPI 1245499920
Payments from drug & device makers
What this record shows
This record is dominated by other: $15,600 of the $17,681 with a category attached, or 88.2%. Convatec Inc. accounts for 88.5% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $16,272, more than ten times the $189 reported in 2019.
Across 78 payments — averaging $226.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$16K
- W. L. Gore & Associates, Inc.$454
- Smith+Nephew$264
- Bard Peripheral Vascular, Inc.$212
- Philips North America LLC$208
- Silk Road Medical, Inc.$103
- plus $798 from 20 others
What the payments were for
- Travel & lodging$1991%
- Food & beverage$1,88111%
- Other$15,60088%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 3 | $15,642 |
| W. L. Gore & Associates, Inc. | 15 | $454 |
| Smith+Nephew | 13 | $264 |
| Bard Peripheral Vascular, Inc. | 7 | $212 |
| Philips North America LLC | 2 | $208 |
| Silk Road Medical, Inc. | 4 | $103 |
| Stryker | 2 | $93 |
| Tactile Systems Technology Inc | 5 | $91 |
| Misonix Inc | 3 | $83 |
| Lemaitre Vascular, Inc. | 4 | $70 |
| Lifenet Health | 1 | $61 |
| Davol Inc. | 3 | $57 |
| Abbott | 2 | $46 |
| Boston Scientific | 1 | $39 |
| Neuros Medical, Inc. | 2 | $37 |
| Terumo Medical Corporation | 1 | $27 |
| Biowound Solutions, Inc. | 1 | $25 |
| Cardiva Medical, Inc. | 1 | $23 |
| Integra Lifesciences Corporation | 1 | $23 |
| Acera Surgical, Inc. | 1 | $22 |
| Triad Life Sciences Inc. | 1 | $21 |
| KCI USA, Inc. | 1 | $20 |
| Access Pro Medical, LLC | 1 | $17 |
| Hydrofera LLC | 1 | $16 |
| Inari Medical, Inc. | 1 | $16 |
| Cvrx, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,681 in reported general payments places this provider in the 80th percentile of 236 vascular surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 24 | $309 |
| Cilostazol | 28 | $268 |
| ClopidogrelClopidogrel Bisulfate | 24 | $212 |
| Lorazepam | 30 | $14 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Pittsburgh
- Michel MakarounPittsburgh$143K
- Efthymios AvgerinosPittsburgh$120K
- Nathan LiangPittsburgh$81K
- Scott ChapmanPittsburgh$21K
- Catherine GoPittsburgh$21K
- Othman Abdul-MalakPittsburgh$18K
- Amanda PhillipsPittsburgh$18K
- Desiree PiconePittsburgh$12K
- Michael SinghPittsburgh$12K
- Bart ChessPittsburgh$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.